Showing results (121-130 of 2,640) with videos related to
Sort By:
Pageof 264
Blood|March 1, 1981
Alloimmunization following platelet transfusion: the absence of a dose-response relationshipJ P Dutcher, C A Schiffer, J Aisner, et al.Blood|November 1, 1981
Long-term follow-up patients with leukemia receiving platelet transfusions: identification of a large group of patients who do not become alloimmunizedJ P Dutcher, C A Schiffer, J Aisner, et al.Cancer|March 1, 1984
Acute doxorubicin toxicity. Relationship to pretreatment liver function, response, and pharmacokinetics in patients with acute nonlymphocytic leukemiaD E Brenner, P H Wiernik, M Wesley, et al.American Journal of Hematology|August 1, 1983
Sustained post-transfusion granulocyte count increments following transfusion of leukocytes obtained from donors with chronic myelogenous leukemiaC A Schiffer, J Aisner, J P Dutcher, et al.Investigational New Drugs|January 1, 1995
Phase II trial of taxol in patients with adenocarcinoma of the upper gastrointestinal tract (UGIT). The Eastern Cooperative Oncology group (ECOG) resultsA I Einzig, S Lipsitz, P H Wiernik, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1993
Infusional cyclophosphamide, doxorubicin, and etoposide in relapsed and resistant non-Hodgkin's lymphoma: evidence for a schedule-dependent effect favoring infusional administration of chemotherapyJ A Sparano, P H Wiernik, A Leaf, et al.Medical Oncology (Northwood, London, England)|November 20, 1998
Inversion of chromosome 16 in accelerated phase of chronic myeloid leukaemia: report of a case and review of the literatureM Colović, G Janković, J Bila, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2000
Mouse mammary tumor virus-like ENV gene sequences in human breast tumors and in a lymphoma of a breast cancer patientP Etkind, J Du, A Khan, et al.American Journal of Hematology|July 1, 1985
Transformation of myeloma into Ph1-negative CML with plasma cell antigensE Paietta, M Goldstein, P Papenhausen, et al.Cancer Research|December 1, 1979
Pharmacokinetic studies during phase I trials of high-dose thymidine infusionsD S Zaharko, B J Bolten, D Chiuten, et al.Pageof 264